Skip to main content
Ashley Sikand, MD, Otolaryngology (ENT), Las Vegas, NV

Ashley Sikand MD FACS

Rhinology & Paranasal Sinus Disease


Physician

Join to View Full Profile
  • 7040 Smoke Ranch RdLas Vegas, NV 89128

  • Phone+1 702-792-6700

  • Fax+1 702-255-0601

Dr. Sikand is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Ashley Sikand, based in Las Vegas, NV, is a specialist in otolaryngology with subspecialties in rhinology and paranasal sinus disease. He completed his education at the University of Alberta in 1985. Dr. Sikand currently serves as a surgeon at the Ear, Nose and Throat Surgery Center since 2018 and has been a physician with the Ear, Nose and Throat Consultants of Nevada since 1995. His areas of expertise include mohs reconstruction, rhinology and sinus disease, as well as otology/neurotology. He has contributed to several publications, notably on balloon sinus dilation, with one cited 41 times. He has also been involved in the clinical trial CABERNET, comparing in-office balloon sinuplasty to medical management. Dr. Sikand is a fellow of the American Academy of Otolaryngology - Head and Neck Surgery.

Education & Training

  • University of Alberta
    University of AlbertaClass of 1985

Certifications & Licensure

  • NV State Medical License
    NV State Medical License 1995 - 2025
  • Otolaryngology
    American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • AcelRx Pharmaceuticals Announces Peer-Reviewed Publication on the Use of DSUVIA® for in-Office Rhinology Procedures
    AcelRx Pharmaceuticals Announces Peer-Reviewed Publication on the Use of DSUVIA® for in-Office Rhinology ProceduresMarch 1st, 2023

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: